P. Went

P. Went, U. Zingg, U. Metzger, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified

S. Pileri, E. Sabattini, P. Zinzani, 2010, Journal of Clinical Pathology.

CDKN 1 B / p 27 expression in peripheral T cell lymphoma not otherwise specified

S. Pileri, E. Sabattini, P. Zinzani, 2022 .

The presence of secretoneurin in human synovium and synovial fluid

P. Went, R. Kirchmair, M. Hukkanen, 1997, Neuroscience Letters.

T-Cell Receptor Dependent and Independent NF-kappa B Activation is a Prognostic Marker and a Therapeutic Target in Peripheral T-cell Lymphoma Not Otherwise Specified

P. Piccaluga, C. Agostinelli, P. Tazzari, 2022, Digital Medicine and Health Technology.

Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway

S. Pileri, P. Zinzani, G. Inghirami, 2014, Leukemia.

Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.

A. Esterman, P. Went, S. Dirnhofer, 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer.

P. Went, U. Zingg, D. Oertli, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Diagnostic Problems in Follow-Up Bone Marrow Biopsies of Patients Treated for Acute and Chronic Leukaemias and MDS

A. Tichelli, P. Went, S. Dirnhofer, 2007, Pathobiology.

An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses

P. Went, C. Münz, Bithi Chatterjee, 2017, Haematologica.

Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3

K. Sotlar, P. Went, A. Tzankov, 2008, Journal of Clinical Pathology.

Rare expression of T-cell markers in classical Hodgkin's lymphoma

S. Pileri, P. Went, A. Tzankov, 2005, Modern Pathology.

Aberrant expression of cell cycle regulators in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma

S. Pileri, S. Geley, P. Went, 2005, Modern Pathology.

Phenotype profiling of primary testicular diffuse large B‐cell lymphomas

P. Went, A. Tzankov, S. Dirnhofer, 2014, Hematological oncology.

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Stefano A Pileri, Andrea Califano, Katia Basso, 2007, The Journal of clinical investigation.

KIT in ovarian carcinoma: disillusion about a potential therapeutic target.

H. Moch, P. Schraml, M. Mihatsch, 2003, Journal of the National Cancer Institute.

Expression of Epithelial Cell Adhesion Molecule (EpCam) in Renal Epithelial Tumors

H. Moch, M. Amin, P. Went, 2005, The American journal of surgical pathology.

Expression and Prognostic Significance of EpCAM

H. Moch, P. Went, S. Dirnhofer, 2008 .

Profound and durable responses with PD-1 immune checkpoint inhibitors in patients with metastatic penile squamous cell carcinoma

P. Went, R. Cathomas, S. Steck, 2020 .

Concomitant hairy cell and acute myeloid leukemia

A. Gratwohl, A. Tichelli, P. Went, 2006, European journal of haematology.

Plasma cell quantification in bone marrow by computer-assisted image analysis.

M Oberholzer, M. Oberholzer, P. Went, 2006, Histology and histopathology.

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

M Vasei, J. Kononen, L. Bubendorf, 2006, British Journal of Cancer.

Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.

S. Pileri, P. Wild, E. Obermann, 2005, Oncology reports.

Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade

A. Steck, P. Went, P. Lyrer, 2007, Journal of Neurology.

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies

S. Pileri, B. Falini, P. Zinzani, 2008, Journal of Clinical Pathology.

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.

S. Pileri, B. Falini, S. Ascani, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.

P. Schüffler, M. Tinguely, P. Went, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

High Specificity of Combined TRAP and DBA.44 Expression for Hairy Cell Leukemia

S. Pileri, G. Sauter, E. Sabattini, 2005, The American journal of surgical pathology.

Lymphoepithelial carcinoma of the salivary glands: case report of a rare cancer and review of the literature

S. Schmid, P. Went, G. Studer, 2014 .

Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.

P. Went, A. Tzankov, S. Dirnhofer, 2008, Human pathology.

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas

P. Went, A. Tzankov, S. Dirnhofer, 2007, Biomarker insights.

Diffuse large B‐cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification

B. Falini, T. Marafioti, S. Ascani, 2002, Histopathology.

The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis

Josef Jiricny, Giancarlo Marra, J. Jiricny, 2009, Molecular Cancer.

Nuclear signalling by tumour-associated antigen EpCAM

Brigitte Mack, Markus Munz, B. Mack, 2009, Nature Cell Biology.

Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.

S. Pileri, P. Went, A. Tzankov, 2010, Human pathology.

Abundant expression of AMACR in many distinct tumour types

L. Bubendorf, G. Sauter, M. Oberholzer, 2006, Pathology.

Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.

S. Cogliatti, P. Went, A. Tzankov, 2012, Human pathology.

Construction and validation of a bone marrow tissue microarray

S. Pileri, C. Agostinelli, P. Went, 2006, Journal of Clinical Pathology.

Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases

S. Pileri, L. Terracciano, P. Went, 2004, Histopathology.

Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease.

S. Pileri, B. Falini, S. Ascani, 2004, The Lancet. Oncology.

Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report

P. Went, S. Haefliger, M. Bihl, 2020, Molecular Biology Reports.

Rare expression of BSAP (PAX-5) in mature T-cell lymphomas

T. Papadopoulos, P. Went, A. Tzankov, 2007, Modern Pathology.

Indolent lymphoma: the pathologist's viewpoint.

S. Pileri, A. Pileri, P. Zinzani, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Tissue microarray technology: principles, pitfalls and perspectives—lessons learned from hematological malignancies

Alexandar Tzankov, P. Went, A. Tzankov, 2005, Experimental Gerontology.

Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19

K. Mertz, A. Stalder, P. Went, 2021, Pathobiology.

JCLINPATH90274 415..420

P. Went, G. Mazzoleni, C. Ensinger, 2022 .

Paraganglioma of the Cervical Sympathetic Trunk

S. Stoeckli, P. Went, K. Landau, 2002, The Annals of otology, rhinology, and laryngology.

A Rare Case of Breast Malignancy in an Adolescent Woman: Lessons Learned from Diagnosis and Management

P. Went, R. Cathomas, Célina Alexandra Fehr, 2020, Breast Care.

Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis

S. Pileri, R. Stoehr, P. Wild, 2005, BMC Cancer.

Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors

D. Jäger, P. Went, A. Jungbluth, 2011, International journal of cancer.

Diffuse Large B-Cell Lymphoma with Overexpression of Cyclin E Substantiates Poor Standard Treatment Response and Inferior Outcome

M. Fiegl, E. Obermann, P. Went, 2006, Clinical Cancer Research.

Gene Expression Analysis of Peripheral T-Cell Lymphoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Cellular Counterparts and Recurrent PDGFRA Deregulation.

K. Basso, S. Pileri, A. Califano, 2005 .

Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases

S. Pileri, P. Went, A. Tzankov, 2003, Modern Pathology.

Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19

K. Mertz, A. Stalder, P. Went, 2021, Frontiers in Immunology.

High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1

S. Pileri, P. Schraml, S. Ascani, 2003, The Journal of pathology.

CDKN1B/ p27 expression in peripheral T cell lymphoma not otherwise speciﬁed

S. Pileri, E. Sabattini, P. Zinzani, 2022 .

A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score

A. Rosenwald, H. Müller-Hermelink, G. Ott, 2009, Journal of hematopathology.

Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas

S. Pileri, A. Reiter, P. Went, 2009, Modern Pathology.

Morphologic changes and altered gene expression in an epithelioid hemangioendothelioma during a ten-year course of disease.

D. Weishaupt, S. Vavricka, P. Went, 2003, Pathology, research and practice.

Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis.

P. Went, D. Franzen, U. Buhlmann, 2008, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: an autopsy study.

P. Went, S. Dirnhofer, M. Bihl, 2011, Human pathology.

[Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas].

P. Went, A. Tzankov, F. Augustin, 2004, Deutsche medizinische Wochenschrift.

Placental site trophoblastic tumor of the mediastinum.

G. Singer, P. Went, S. Dirnhofer, 2005, Human pathology.

Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

L. Pleyer, R. Greil, P. Went, 2007, Wiener klinische Wochenschrift.

Hepatocellular carcinoma in variegate porphyria: a serious complication.

X. Schneider-Yin, P. Went, J. Frank, 2010, Acta dermato-venereologica.

Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease

O. Donzé, P. Went, S. Dirnhofer, 2007, Leukemia.

CD5 expression in de novo diffuse large B-cell lymphomas.

P. Went, A. Tzankov, A. Zimpfer, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[Meningothelial meningioma in a mature cystic teratoma of the ovary].

P. Went, M. Tolnay, M Tolnay, 2007, Der Pathologe.

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies

S. Pileri, B. Falini, P. Zinzani, 2008, Journal of Clinical Pathology.

EpCAM expression in primary tumour tissues and metastases : an immunohistochemical analysis

P. Went, G. Mazzoleni, C. Ensinger, 2022 .

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas

P. Went, A. Tzankov, S. Dirnhofer, 2007, Biomarker Insights.

Frequency of CD5-expression and its association with trisomy 3 and 7 in diffuse large B-cell lymphoma. A tissue-microarray analysis of 306 cases

S. Pileri, P. Went, A. Tzankov, 2004 .

Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.

J. Passweg, P. Went, J. Schwaller, 2008, Experimental hematology.

Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

S. Pileri, B. Falini, P. Piccaluga, 2008 .

Lack of protein expression of the simian virus 40 large T antigen in human lymphomas

S. Pileri, P. Went, A. Tzankov, 2008, Journal of medical virology.

Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.

S. Pileri, P. Went, A. Tzankov, 2010, Human Pathology.

Nuclear signalling by tumour-associated antigen EpCAM

B. Mack, O. Gires, P. Went, 2009, Nature Cell Biology.

Edrecolomab in the adjuvant treatment of colorectal carcinoma

P. Went, S. Dirnhofer, G. Gastl, 2003, The Lancet.

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

P. Went, G. Mazzoleni, C. Ensinger, 2022 .

Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors

D. Jäger, P. Went, A. Jungbluth, 2011, International journal of cancer.

Placental barrier in acute myeloid leukaemia

P. Went, M. Decker, 2009, British journal of haematology.

Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.

J. Passweg, P. Went, J. Schwaller, 2008, Experimental hematology.

R. Malekzadeh, Y. Teo, M. Coleman, 2022, The Lancet. Child & adolescent health.